Closed
Source verified July 23, 2026
Funding for Company-driven RNA Innovation (AReNA)
Supports company-driven RNA innovation
Receipt of requests is now closed
Get notified about updates to this grant.
Latest source updateLast Update: August 13, 2026Latest change: The AReNA page now says the previous call has closed and that new funding rounds and application deadlines will be announced later.View change
Latest source update
Last Update: August 13, 2026
Latest change: The AReNA page now says the previous call has closed and that new funding rounds and application deadlines will be announced later.
AReNA call closed; next rounds pending
The AReNA page now replaces the deadline section with Upcoming Funding Rounds and states that the previous call for proposals has closed. New funding rounds and application deadlines will be announced shortly.
Funding available
Varies by project
Deadline
Closed
Location
Quebec, Canada
Overview
This program supports company-driven RNA innovation with a total budget of $3M. It aims to accelerate the commercialization of Québec biopharmaceutical innovations and strengthen company competitiveness.
Receipt of requests is now closed
Get notified about updates to this grant.
At a glance
Funding available
Financing goals
- Develop a new product or service
- Conduct research and development activities
- Launch or market a product/service
Eligible Funding
- Varies by project
Funds Providers
Eligible candidates
Eligible Industries
- All industries
Location
- Quebec
Legal structures
- For-profit business
Annual revenue
- All revenue ranges
Organisation size
- All organization sizes
Audience
- All groups
Next Steps
1
Determine your project
2
Validate your eligibility
Activities funded
- Development of innovative technologies for the RNA therapy sector.
- Commercialization of Québec biopharmaceutical innovations.
Official resources
Eligibility
Eligible geographic areas
- Quebec
How to apply
- Step 1: Submit letter of intent
- Send the non-selective letter of intent by March 16, 2026.
- Step 2: Submit full application
- Submit the complete application by March 30, 2026.
- Send the application by email to appliquez-apply@cqdm.org.
Processing and Agreement
- A non-selective letter of intent is submitted first.
- Complete applications are then submitted for review.
- Applications are sent by email to appliquez-apply@cqdm.org.
Additional information
- The program is funded by the Ministry of Economy, Innovation and Energy (MEIE).
- It is managed by CQDM as part of AReNA, Québec’s RNA Hub.
- Applicants are directed to the AReNA website for full program details.
Contacts
Frequently Asked Questions about the Funding for Company-driven RNA Innovation (AReNA) Program
What is the Funding for Company-driven RNA Innovation (AReNA)?
This program supports company-driven RNA innovation with a total budget of $3M. It aims to accelerate the commercialization of Québec biopharmaceutical innovations and strengthen company competitiveness.
What expenses are eligible under Funding for Company-driven RNA Innovation (AReNA)?
Development of innovative technologies for the RNA therapy sector.
Commercialization of Québec biopharmaceutical innovations.
Who can I contact for more information about the Funding for Company-driven RNA Innovation (AReNA)?
You can contact Quebec Consortium for Drug Discovery (CQDM) by email at appliquez-apply@cqdm.org.
Where is the Funding for Company-driven RNA Innovation (AReNA) available?
The Funding for Company-driven RNA Innovation (AReNA) program is available the province of Quebec.
Is the Funding for Company-driven RNA Innovation (AReNA) a grant, loan, or tax credit?
Funding for Company-driven RNA Innovation (AReNA) is a Other Support
Who are the financial supporters of the Funding for Company-driven RNA Innovation (AReNA)?
Funding for Company-driven RNA Innovation (AReNA) is funded by Quebec Consortium for Drug Discovery (CQDM)